Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats
Journal of Proteomics · 2024
DOI: 10.1016/j.jprot.2024.105227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2024. Verfasst von Lizhou Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China. Hauptthemen laut MEDLINE: Carbon Tetrachloride, Liver Cirrhosis, Network Pharmacology, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Scientific Research Fund of Liaoning Provincial Education Department.
Abstract (Originalsprache)
Polygoni Orientalis Fructus (POF), a dried ripe fruit of Polygonum orientale L., is commonly used in China for liver disease treatment. However, its therapeutic mechanism remains unclear. The aim of this study was to elucidate the effects of POF on the regulation of endogenous metabolites and identify its key therapeutic targets in hepatic fibrosis (HF) rats by integrating network pharmacology and metabolomics approaches. First, serum liver indices and histopathological analyses were used to evaluate the therapeutic effects of POF on carbon tetrachloride (CCl4)-induced HF. Subsequently, differential metabolites and potential therapeutic targets of POF were screened using plasma metabolomics and network pharmacology, respectively. The key targets of POF were identified by overlapping differential metabolite-associated targets with the potential targets and validated by molecular docking and ELISA experiments. The results showed that POF effectively alleviated HF in rats. A total of 51 metabolites related to HF were screened, and 24 were associated with POF. 232 potential therapeutic targets were identified by network pharmacology analysis. Finally, six key targets were identified through a combined analysis. Furthermore, molecular docking and ELISA validation revealed that AGXT, PAH, and NOS3 are targets of POF action, while CBS, ALDH2, and ARG1 were identified as potential targets. SIGNIFICANCE: POF is now commonly used in the treatment of liver disease, but its mechanism of action remains unclear. Current studies on metabolomics of liver disease primarily focuse on the interpretation of differential metabolites and related metabolic pathways. This research delves into the intricate details of metabolomics findings via network pharmacology to uncover the targets and pathways of drug action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China.
- School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China.
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China. Electronic address: wangmiao@syphu.edu.cn.
Förderung
- Scientific Research Fund of Liaoning Provincial Education Department
Zitieren
APA
Ma, L., Chen, Y., Yue, R., Li, Z., Wang, Y., Bian, Y., & Wang, M. (2024). Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2024.105227
Vancouver
Ma L, Chen Y, Yue R, Li Z, Wang Y, Bian Y, et al. Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats. Journal of Proteomics. 2024. doi:10.1016/j.jprot.2024.105227
BibTeX
@article{Ma2024,
author = {Ma, Lizhou and Chen, Yu and Yue, Rong and Li, Ziyu and Wang, Yibo and Bian, Yanggang and Wang, Miao},
title = {Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats},
journal = {Journal of Proteomics},
year = {2024},
doi = {10.1016/j.jprot.2024.105227}
}
EUVIMED